The global shift in active pharmaceutical ingredient (API) sourcing from China to India is redefining the supply chain, offering new opportunities while introducing additional challenges for drug manufacturers worldwide. As India emerges as a key player in API production, pharmaceutical companies must adapt to the complexities for sourcing in this evolving market.
API sourcing has always been a complex process, and this transition adds a new layer of intricacy. To remain competitive, pharma companies must now navigate a dynamic landscape of quality, regulatory, pricing, and supply chain factors.
The Basics: What API Sourcing Must Supply
Before delving into the complexities of shifting API sources, it is crucial to first establish a clear understanding of the fundamental requirements that must be met by any API supplier.
Product Quality: It’s a dealbreaker. If your source can’t consistently meet quality requirements for safety and efficacy, it’s imperative you move on to another source.
Regulatory Compliance: This goes hand in hand with meeting quality specifications. Without regulatory approvals you can’t bring your product to market.
Capacity and Scalability: Does the source you’re investigating have the capability to manufacture the APIs you need in the timeframe you require? What are their lead time requirements? When your orders scale up, can they scale up their production to fulfill them?
Price: Cost is a major criterion in your sourcing strategies. You have to balance of cost of the APIs with the need for consistent quality. Shipping and transportation costs also need to be considered in terms of savings from economies of scale with large manufacturers in another country.
Having established the essential criteria for evaluating an API source, it’s important to understand the broader implications of sourcing changes. As the API industry navigates the shift towards new sourcing regions like India, several concerns emerge that could impact your sourcing decisions.
Changing Market Dynamics Create Vulnerabilities for Pharma
The global pandemic brought about devastating and debilitating challenges, imparting invaluable lessons to the pharmaceutical industry. One stark and ongoing lesson has been the vulnerability of relying on a single geographic source, particularly for Active Pharmaceutical Ingredients (APIs). APIs are the lifeblood of the industry, making the selection of a reliable and diverse supply source absolutely mission-critical.
China has long been the primary source for APIs and their raw starting materials, a reliance that has become a significant pain point for drug manufacturers amid geopolitical tensions and concerns about quality control. While China remains a major supplier, a shift is underway as countries explore reshoring and reducing dependence on outside sources. The industry has looked elsewhere for API sourcing, with India making significant strides in this area. Today, India has become a major competitor in the API market.
While the shift from China to India for API sourcing is a positive development, it introduces significant changes and presents the following challenges for the pharmaceutical industry:
- Uncertainty in Supply Chain Stability: The geographic change creates challenges in ensuring consistent supply and avoiding disruptions during the transition.
- Vetting and Compliance: Difficulties arise in vetting new Indian API manufacturers, assessing long-term capacity, and ensuring regulatory compliance with global standards. The Central Drugs Standard Control Organization (CDSCO) is the National Drugs Regulatory Authority of the Government of India but there still may be regulatory nuances within its various regions and states.
- Market Adjustments: Potential price volatility and longer lead times as the market adjusts to new sourcing dynamics.
- Regulatory and Supplier Management Challenges: Navigating and learning regulatory hurdles in new geographic areas and managing increased complexity with a more diverse supplier base.
- Cultural and Communication Barriers: Potential language and cultural barriers when shifting to a new geographic region.
From Challenges to Solutions: Partnering with the Right API Sourcing Experts
API sourcing is undeniably complex and becoming increasingly so as India emerges as a significant player in the market. It’s also undeniable that the API market is continually evolving. Today’s vulnerabilities relate to moving sourcing from China to India. Tomorrow’s may be moving to supplier in Europe or the United States. Change is the only constant in the pharma industry.
To manage this evolving complexity and secure the right API supplier for your needs, partnering with experts who specialize in API sourcing is crucial. LGM Pharma brings 50 years of experience in connecting clients with the ideal strategic API manufacturers while handling logistics and regulatory requirements. Our expertise lies in staying ahead of the constant changes in this field.
Considering a potential API supplier in India? LGM Pharma ensures that the manufacturer meets 21CFR requirements, that their facility and operations are FDA-inspected, and that they’ve received a clean FDA bill of health. Once the quality systems meet standards, our team conducts thorough audits. All essential criteria (including the basics listed earlier) are meticulously covered and discussed with your team to determine the best API supplier. Ultimately, the decision remains in your hands.
LGM’s capabilities extend beyond an API sourcing database. We offer an extensive network of prequalified, geographically distributed API manufacturers, having facilitated over 6,000 successful deliveries in the past three years. For more information, contact us here.